A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis

Trial Profile

A Phase II Double-blind, Randomized, Comparator-controlled Study of the Safety and Efficacy of Zoenasa Rectal Gel (Mesalamine Plus N-acetylcysteine) in Subjects With Left-sided Ulcerative Colitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2014

At a glance

  • Drugs Mesalazine/acetylcysteine (Primary) ; Mesalazine
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors Altheus Therapeutics
  • Most Recent Events

    • 28 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
    • 09 Jan 2014 Topline results are expected in to be available in March or early April 2014, according to an Altheus Therapeutics media release.
    • 07 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top